4.8 Article

Zwitterionic Janus Dendrimer with distinct functional disparity for enhanced protein delivery

期刊

BIOMATERIALS
卷 215, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2019.119233

关键词

Janus dendrimers; Protein delivery; Zwitterionic surfaces; Protein binding; Protein repelling

资金

  1. NIH/NIGMS [1R01 GM130941-01]
  2. NIH/NIBIB [1R21EB019607]
  3. NIH/NHLBI [1R01HL139824-01]
  4. New York State Department of Health/PETER T. ROWLEY breast cancer research award
  5. Carol M. Baldwin Breast Cancer Research Foundation
  6. Maureen T. O'Hara TEAL THERE's A CURE
  7. Christine Schoeck Blakely Ovarian Cancer Research Foundation

向作者/读者索取更多资源

The development of a facile protein delivery vehicle is challenging and remains an unmet demand for clinical applications. The well-defined structure and functionality of a nanocarrier are highly desirable for the reproducibility and regulatory compliance. Herein, we report for the first time a novel Janus dendrimer (JD) system, comprised of two distinct dendrons with superior protein binding and protein repelling properties, respectively, for efficient spontaneous protein loading and enhanced in vivo protein delivery. Core-forming dendron is tethered with a combination of charged and hydrophobic moieties, which coat protein surface efficiently via the multivalent and synergistic interactions. Zwitterionic peripheries on the counter dendron endow the nanoparticle ( < 20 nm) with a highly hydrophilic and antifouling surface, which efficiently prevents serum protein adsorption and exchange as demonstrated in biolayer interferometry assay, therefore, reducing premature protein release. Surprisingly, JD nanocarriers containing biomimicking glycerylphosphorylcholine (GPC) surface significantly enhanced the intracellular uptake of protein therapeutics specifically in cancer cells, compared with zwitterionic carboxybetain (CB)-JD and PEGylated nanocarriers. The zwitterionic JD nano carriers greatly prolonged the in vivo pharmacokinetic profiles of payloads relative to the PEGylated nano carriers. Janus nanocarrier controlled the in vivo release of insulin and improved the blood sugar control in mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据